SysBio NIH Working Group
This is the trans-NIH Working Group that oversees the development, implementation, communication, and assessment of the Common Fund program.
Co-Chairs:
Co-Chairs are Institute or Center (IC) directors or IC senior staff who lead the Working Group and have the authority to approve major activities and funding actions.
- Lindsey A. Criswell, M.D., Ph.D., D.Sc.
Director
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) - Douglas Sheeley, D.Sc.
Acting Director, Office of Strategic Coordination (OSC)
Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI)
Office of the Director (OD)
Leadership Team & Points of Contact:
Working Group Coordinators, Project Team Leaders, and the Program Leader serve as the day to day leadership for the program and the Working Group. Also included here are points of contact for areas of program management.
Working Group Coordinators:
- Robert H. Carter, M.D.
Deputy Director
National Institute of Arthritis and Musculoskeletal Diseases (NIAMS)
Common Fund Program Leaders:
- Mary Ann Wu, Ph.D.
Venture Program Lead
Oculomics Initiative Lead
Office of Strategic Coordination (OSC)
Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI)
Office of the Director (OD) - Haluk Resat, Ph.D.
SysBio Initiative Lead
Office of Strategic Coordination (OSC)
Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI)
Office of the Director (OD)
Points of Contact:
- David Dzamashvili
Program Analyst Business Operations and Analysis Contact
Office of Strategic Coordination (OSC)
Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI)
Office of the Director (OD) - Jana Eisenstein, M.S.
Scientific Program Manager
Division of Extramural Research
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) - Kristina Faulk
Other Transactions (OT) Advisor
Office of Strategic Coordination (OSC)
Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI)
Office of the Director (OD) - Katelynn Milora, Ph.D.
Health Specialist Strategic Planning, Evaluation, and Communications (SPEC) Contact
Office of Strategic Coordination (OSC)
Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI)
Office of the Director (OD)
Members:
The Working Group Members are staff from multiple NIH Institutes and Centers who provide input from their Institute or Center’s perspective.
- Christine M. Colvis, Ph.D.
Director, Office of Drug Development Partnership Programs
National Center for Advancing Translational Sciences (NCATS) - Stefania Dell'Orso, Ph.D.
Co-Director, Office of Science and Technology
Chief, Genomic Technology Section
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) - Temesgen Fufa, Ph.D.
Program Director, Division of Genome Sciences
National Human Genome Research Institute (NHGRI) - Susan K. Gregurick, Ph.D.
Associate Director for Data Science
Director, Office of Data Science Strategy (ODSS) - Sweta Ladwa, Ph.D.
Chief, Scientific Solutions Delivery Branch
Information Technology and Applications Center
National Heart, Lung, and Blood Institute (NHLBI) - Mette Peters, Ph.D.
Senior Advisor, Data Science and Data Sharing
National Institute on Aging (NIA) - Erna Petrich
Other Transactions (OT) Agreements Officer
Office of Strategic Coordination (OSC)
Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI)
Office of the Director (OD) - Christine Swanson-Fischer, Ph.D.
Program Director, Division of Neuroscience
Movement Disorders and Neurodegeneration
National Institute of Neurological Disorders and Stroke (NINDS) - Ursula Utz, Ph.D.
Program Director, Division of Neuroscience
Neural Environment
National Institute of Neurological Disorders and Stroke (NINDS) - Isaiah Whittaker
Other Transactions (OT) Agreements Specialist
Office of Strategic Coordination (OSC)
Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI)
Office of the Director (OD) - Ashley Xia, M.D., Ph.D.
Program Director, Division of Diabetes, Endocrinology, & Metabolic Diseases
Division of Translational Toxicology
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)